United States · FDA National Drug Code directory
TAUVID
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0002-1220_28ed503a-b3ed-40a3-a6e8-acdf613fa748
- Product NDC
- 0002-1220
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Flortaucipir F-18
- Labeler
- Eli Lilly and Company
- Marketing category
- NDA
- Marketing start / end (source format)
- 20220701
- Source listing expiry
- 20271231
Source-listed ingredients
- FLORTAUCIPIR F-18 — 100 mCi/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CAN (0002-1220-48) / 100 mL in 1 VIAL, MULTI-DOSE · 0002-1220-48
- 1 VIAL, MULTI-DOSE in 1 CAN (0002-1220-50) / 50 mL in 1 VIAL, MULTI-DOSE · 0002-1220-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →